Tilray Brands (NASDAQ:TLRY) Trading Down 3.2% – Should You Sell?

Tilray Brands, Inc. (NASDAQ:TLRY) traded down 3.2% during mid-day trading on Tuesday . The company traded as low as $7.22 and last traded at $7.36. 4,047,462 shares traded hands during trading, a decline of 3% from the average session volume of 4,194,183 shares. The stock had previously closed at $7.60.

Tilray Brands News Summary

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Acquired key BrewDog assets for £33m expected to materially expand Tilray’s beverage footprint — management projects the assets could add roughly $200M in annual net revenue and contribute $6–8M adjusted EBITDA in fiscal 2027 while helping Tilray target ~$1.2B of annualized consolidated revenue. Tilray Brands Acquires BrewDog — Yahoo/GlobeNewswire
• Positive Sentiment: Signed an exclusive licensing agreement with Carlsberg (effective Jan 1, 2027) to strengthen Tilray’s U.S. beverage footprint and distribution — a strategic partnership that could accelerate international rollouts of Tilray beverage brands. Tilray Strengthens U.S. Footprint With Carlsberg Partnership — InsiderMonkey
• Neutral Sentiment: Trading was temporarily halted earlier for “news pending,” indicating the company-managed announcement cadence drove intraday volatility; investors should expect elevated volume and short-term price swings around M&A disclosures.
• Neutral Sentiment: Tilray hosted an M&A call (transcript available) to discuss deal rationale and integration plans — useful for investors to review management’s assumptions, timing and cost synergies. Tilray M&A Call Transcript — Seeking Alpha
• Negative Sentiment: Market skepticism surfaced immediately — some investors question whether the acquisition price, integration risks and modest near‑term EBITDA justify the deal, and that skepticism has weighed on the stock. Tilray Stock Falls As BrewDog Deal Faces Skepticism — Investing.com
• Negative Sentiment: BrewDog administration led to closures and nearly 500 job cuts in the UK; these reputational and operational disruptions could create short‑term integration hurdles and PR risk for Tilray. BrewDog Shuts Bars as Rescue Bid Looms — Telegraph
• Negative Sentiment: Management warns licensing-transfer timing will limit meaningful EBITDA contribution until fiscal 2027, so the deal may be a near‑term drag on profitability even if strategically attractive longer term. Quiver Quant Summary of BrewDog Acquisition

Wall Street Analysts Forecast Growth

A number of brokerages have commented on TLRY. Canaccord Genuity Group assumed coverage on Tilray Brands in a report on Tuesday, January 27th. They set a “hold” rating for the company. Zacks Research raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, February 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tilray Brands in a research note on Wednesday, January 21st. ATB Cormark Capital Markets upgraded shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 10th. Finally, Wall Street Zen upgraded shares of Tilray Brands from a “sell” rating to a “hold” rating in a report on Sunday, February 22nd. One analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Tilray Brands currently has an average rating of “Hold” and a consensus target price of $13.33.

Tilray Brands Price Performance

The firm has a market cap of $857.51 million, a PE ratio of -0.33 and a beta of 1.95. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.81 and a quick ratio of 1.72. The business’s fifty day moving average is $8.52 and its 200-day moving average is $11.05.

Tilray Brands (NASDAQ:TLRY) last posted its quarterly earnings data on Thursday, January 8th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.12. The business had revenue of $217.51 million for the quarter, compared to the consensus estimate of $211.15 million. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.During the same quarter in the prior year, the business earned ($0.03) earnings per share. On average, research analysts predict that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Tilray Brands

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Silverlake Wealth Management LLC purchased a new stake in shares of Tilray Brands during the third quarter worth $25,000. Oppenheimer & Co. Inc. purchased a new stake in Tilray Brands during the 3rd quarter worth about $25,000. Unified Investment Management bought a new position in Tilray Brands in the 3rd quarter worth about $26,000. J.W. Cole Advisors Inc. boosted its stake in Tilray Brands by 203.2% in the 2nd quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock worth $30,000 after purchasing an additional 48,177 shares during the period. Finally, Y Intercept Hong Kong Ltd purchased a new position in Tilray Brands during the 3rd quarter valued at about $30,000. Institutional investors own 9.35% of the company’s stock.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.